About Us
Company Profile

Suzhou Chung-Hwa Chemical&Pharmaceutical Industrial Co.,Ltd.(hereinafter referred to as Suzhou Chung-Hwa Chemical&Pharmaceutical) was established in April 1993, Yongan Road factory was officially opened in 2014, located in the Jiangnan water town - Suzhou National High-tech Industrial Development Zone, covering an area of about 60,000 square meters, is a national high-tech modern pharmaceutical enterprise invested and established by Cenra, integrating scientific research, production and sales, and is also one of the first batch of pharmaceutical enterprises in China to pass GMP certification.

Suzhou Chung-Hwa Chemical&Pharmaceutical has established an independent and beautiful research building, built a preparation trial production workshop that meets GMP requirements, strived to build an independent R&D and innovation platform with an international vision, and established a cross-strait joint research institute with Cenra Research Institute, relying on Cenra's profound scientific research accumulation, adhering to the cutting-edge pharmaceutical concept and technological innovation orientation, and building core technology advantages. By equipping with the world's leading cutting-edge production equipment and intelligent inspection instruments, we fully implement GMP standards and precise quality control system.

Suzhou Chung-Hwa Chemical&Pharmaceutical has a sound sales network and after-sales service system, and the sales network covers the whole country, covering 31 provinces and cities and more than 1,000 counties and cities across the country. Marketing is committed to large-scale and diversified development, offline hospitals, pharmacies, and clinics, and its products cover more than 12,000 hospitals across the country. It has established good cooperative relations with well-reputable and powerful mainstream B2B e-commerce platforms such as "Pharmacist", "Yaojingcai" and "1 Yaocheng", and is committed to allowing more patients to use the high-quality drugs produced by Suzhou Chung-Hwa.

At present, the main drug categories include: digestive system drugs, cardiovascular system drugs, musculoskeletal system drugs, endocrine system drugs, anti-infective drugs and other functional nutrition products. In addition to the pharmaceutical field, Suzhou Chung-Hwa Pharmaceutical established a subsidiary, Suzhou Chung-Hwa Le Huo Jian Kang Co.,Ltd.. in 2021, and has its own brands such as MIAJACK and HEALTH CRANE, actively moving towards health fields such as personal care products and health food.

Nowadays, with the vigorous development of the Internet, Suzhou Chung-Hwa Chemical&Pharmaceutical has always adhered to the vision of being a "trustworthy health cause in the Chinese world", advocated the core values of "innovation, health, passion and care", and constantly innovated to keep up with the pace of the times. In addition to consolidating the existing professional drug production capacity and continuing to expand the scale, it also began to plan future cooperation with online and offline medical systems, aiming to build a smart technology health industry. No matter where you are in the world, Suzhou Chung-Hwa Chemical&Pharmaceutical will embrace health and happiness with you every day!


About Cenra

Founded in 1952, Cenra has been innovating and developing in the industry for more than 70 years, and has continuously improved the quality of its products and services. With many professional talents, it is one of the pharmaceutical factories with the most drug licenses, and it is also the most leading pharmaceutical factory in Taiwan's pharmaceutical industry.

Cenra has established many affiliated enterprises, such as Cenra API Solutions、Cenra Healthcare、Cenra Senior Care.; In addition to R&D and production of drugs, it also develops medical, health supplies, health services, and operation and marketing. On the basis of professional division of labor, it can also vertically integrate the resources of related enterprises, enter the latest technology, the latest drugs and the latest services into the world, and truly become the most trustworthy health cause!

Company Profile
*Data updated in 2025
  • 32
    32
    Founded 32 years ago
  • 39
    39
    39 authorized patents
  • 34
    34
    34 invention patents authorized
  • 40
    40
    40 items passed the consistency evaluation
Corporate Culture
  • Vision
    A trustworthy health business in the Chinese world
  • Values
    Innovation, Healthy, Enthusiasm, Care
Milestones
  • 1993
    The U.S. Dingmao Corporation indirectly invested in mainland China and established Suzhou Chung-Hwa Chemical & Pharmaceutical Industrial Co., Ltd.
  • 1996
    Suzhou Chung-Hwa Chemical & Pharmaceutical Jinshan Road Factory completed and put into use
  • 1997
    Suzhou Chung-Hwa Chemical & Pharmaceutical became one of the first companies to meet the GMP standards of the State Drug Administration and the first in Jiangsu Province.
  • 1998
    Suzhou Chung-Hwa Chemical & Pharmaceutical passed the cGMP certification of the whole factory by the national health department
  • 2009
    Some products of Suzhou Chung-Hwa Chemical &Pharmaceutical passed the Japanese PMDA factory inspection certification; Huayiping® voglibose tablets was approved for marketing
  • 2010
    Suzhou Chung-Hwa Chemical & Pharmaceutical Yong'an Road Factory Groundbreaking Ceremony
  • 2014
    Suzhou Chung-Hwa Chemical & Pharmaceutical Yong'an Road Factory officially opened; Suzhou Chung-Hwa Yumin obtained operating permit and business license
  • 2015
    Suzhou Chung-Hwa Yumin passed the GSP certification; some products of Suzhou Chung-Hwa Chemical & Pharmaceutical passed the Japanese PMDA factory inspection certification
  • 2017
    Suzhou Chung-Hwa Chemical & Pharmaceutical's key product "Lifeibo®" enters national medical insurance
  • 2019
    Fulexin® Cefuroxime Axetil Tablets passed the consistency evaluation
  • 2020
    Keluo® Cefaclor Capsules and Xiwading® Cetirizine Hydrochloride Tablets passed the consistency evaluation and were selected for national centralized procurement
  • 2021
    Suzhou Chung-Hwa Health Industry Co., Ltd. was established, oral care brand Miyajieke® was established, and Helekang® brand was established; Huayiping® Voglibose Tablets passed the consistency evaluation
  • 2023
    Suzhou Chung-Hwa Chemical & Pharmaceutical celebrated its 30th anniversary and was shortlisted for the China Brand Innovation and Development Project; Yulening® Telmisartan Tablets and Lifeibo® Calcium Polycarbophil Tablets passed the consistency evaluation; the first generic version of calcium polycarbophil granules was approved for marketing; Huayiping® was selected for national centralized procurement
  • 2024
    Elite youth from both sides of the Taiwan Straits won awards santongding® Rivaroxaban tablets approved, deemed to have passed review
  • 1993
    The U.S. Dingmao Corporation indirectly invested in mainland China and established Suzhou Chung-Hwa Chemical & Pharmaceutical Industrial Co., Ltd.
  • 1996
    Suzhou Chung-Hwa Chemical & Pharmaceutical Jinshan Road Factory completed and put into use
  • 1997
    Suzhou Chung-Hwa Chemical & Pharmaceutical became one of the first companies to meet the GMP standards of the State Drug Administration and the first in Jiangsu Province.
  • 1998
    Suzhou Chung-Hwa Chemical & Pharmaceutical passed the cGMP certification of the whole factory by the national health department
  • 2009
    Some products of Suzhou Chung-Hwa Chemical &Pharmaceutical passed the Japanese PMDA factory inspection certification; Huayiping® voglibose tablets was approved for marketing
  • 2010
    Suzhou Chung-Hwa Chemical & Pharmaceutical Yong'an Road Factory Groundbreaking Ceremony
  • 2014
    Suzhou Chung-Hwa Chemical & Pharmaceutical Yong'an Road Factory officially opened; Suzhou Chung-Hwa Yumin obtained operating permit and business license
  • 2015
    Suzhou Chung-Hwa Yumin passed the GSP certification; some products of Suzhou Chung-Hwa Chemical & Pharmaceutical passed the Japanese PMDA factory inspection certification
  • 2017
    Suzhou Chung-Hwa Chemical & Pharmaceutical's key product "Lifeibo®" enters national medical insurance
  • 2019
    Fulexin® Cefuroxime Axetil Tablets passed the consistency evaluation
  • 2020
    Keluo® Cefaclor Capsules and Xiwading® Cetirizine Hydrochloride Tablets passed the consistency evaluation and were selected for national centralized procurement
  • 2021
    Suzhou Chung-Hwa Health Industry Co., Ltd. was established, oral care brand Miyajieke® was established, and Helekang® brand was established; Huayiping® Voglibose Tablets passed the consistency evaluation
  • 2023
    Suzhou Chung-Hwa Chemical & Pharmaceutical celebrated its 30th anniversary and was shortlisted for the China Brand Innovation and Development Project; Yulening® Telmisartan Tablets and Lifeibo® Calcium Polycarbophil Tablets passed the consistency evaluation; the first generic version of calcium polycarbophil granules was approved for marketing; Huayiping® was selected for national centralized procurement
  • 2024
    Elite youth from both sides of the Taiwan Straits won awards santongding® Rivaroxaban tablets approved, deemed to have passed review
Honors
2023 Advanced Enterprise Tax Contribution Award
In 2023, we will pay tribute to enterprises that take responsibility for fighting the epidemic and ensuring supply
2022 Jiangsu Province Specialized, Refined, Special and Innovative Small and Medium Enterprises
High-tech Enterprises in 2022
Demonstration Enterprise for Transformation of Scientific and Technological Innovation Achievements in 2022
Units (individuals) with outstanding contributions to the COVID-19 epidemic prevention and control in 2020
2020 Suzhou Hushuguan Economic and Technological Development Zone Advanced Enterprise Economic Contribution Award
Entrepreneurs with Important Contributions in Suzhou Hushuguan Economic and Technological Development Zone in 2020
Suzhou High-tech Zone (Huqiu District) Harmonious Labor Relations Enterprise in 2019
Top Ten Enterprises with Harmonious Labor Relations in 2016
2016 Jiangsu Province Famous Trademark
2015 Jiangsu Province Science and Technology Small and Medium Enterprises
2014 Suzhou Chung-Hwa Chemical Pharmaceutical Preparation Engineering Technology Research Center
2013 Suzhou City Well-known Trademark
2013 Enterprise Technology Center recognized by Suzhou Municipal People's Government
2012 Suzhou City AA-level labor security credit unit
2012 Suzhou City A-level Labor Security Credit Certificate
AAA credit rating in 2007
2005 Suzhou City Foreign-funded R&D Institution
2005 Caring Enterprise
In 2005, Suzhou City was awarded as an advanced unit in the "Price Integrity" campaign
Jiangsu Province Certified Enterprise Technology Center
Jiangsu Provincial Enterprise Graduate Workstation
Learn More
Honors
2023 Advanced Enterprise Tax Contribution Award
In 2023, we will pay tribute to enterprises that take responsibility for fighting the epidemic and ensuring supply
2022 Jiangsu Province Specialized, Refined, Special and Innovative Small and Medium Enterprises
High-tech Enterprises in 2022
Demonstration Enterprise for Transformation of Scientific and Technological Innovation Achievements in 2022
Units (individuals) with outstanding contributions to the COVID-19 epidemic prevention and control in 2020
2020 Suzhou Hushuguan Economic and Technological Development Zone Advanced Enterprise Economic Contribution Award
Entrepreneurs with Important Contributions in Suzhou Hushuguan Economic and Technological Development Zone in 2020
Suzhou High-tech Zone (Huqiu District) Harmonious Labor Relations Enterprise in 2019
Top Ten Enterprises with Harmonious Labor Relations in 2016
2016 Jiangsu Province Famous Trademark
2015 Jiangsu Province Science and Technology Small and Medium Enterprises
2014 Suzhou Chung-Hwa Chemical Pharmaceutical Preparation Engineering Technology Research Center
2013 Suzhou City Well-known Trademark
2013 Enterprise Technology Center recognized by Suzhou Municipal People's Government
2012 Suzhou City AA-level labor security credit unit
2012 Suzhou City A-level Labor Security Credit Certificate
AAA credit rating in 2007
2005 Suzhou City Foreign-funded R&D Institution
2005 Caring Enterprise
In 2005, Suzhou City was awarded as an advanced unit in the "Price Integrity" campaign
Jiangsu Province Certified Enterprise Technology Center
Jiangsu Provincial Enterprise Graduate Workstation
  • 2023 Tax Contribution Award
  • 2023致敬抗疫保供责任担当企业
  • 2022江苏省专精特新中小企业
  • 2022高新技术企业
  • 2022年度科技创新成果转化示范企业
  • 2020新冠肺炎疫情防控捐赠突出贡献单位
  • 2020经济贡献奖
  • 2020重要贡献企业家
  • 2019劳动关系和谐企业
  • 2016十佳劳动关系和谐企业
  • 2016江苏省著名商标
  • 2015.06.30江苏省科技型中小企业证书
  • 2014苏州市Chung-Hwa化学药物制剂工程技术研究中心
  • 2013苏州市知名商标
  • 2013企业技术中心
  • 2012荣誉证书
  • 2012劳动保障诚信等级证
  • 2007AAA
  • 2005苏州市外资研发机构
  • 2005爱心企业
  • 2005先进单位
  • 江苏省认定企业技术中心
  • 企业研究生工作站
  • 20220826一种粉碎装置
  • 20220826一种去衣装置
  • 20220421一种药品片剂去皮固定装置
  • 20220322一种具有防堵塞结构的微通道反应器
  • 20220318一种化工制药设备的清洁装置
  • IP01一种盐酸坦洛新的缓控释制剂及其制备方法
  • IP02一种治疗糖尿病性神经病变的药物组合物及其制备方法
  • IP03一种治疗心血管疾病的复方制剂及其制备方法
  • IP04一种糖尿病治疗药物组合物及其制备方法 (2)
  • IP05一种阿卡波糖药物组合物及其制备方法
  • IP06一种用于治疗肠道疾病的药物组合物及其制备方法
  • IP07一种伊曲康唑微丸及其制备方法与制剂
  • IP08一种聚卡波非钙低聚物的测定方法
  • IP09一种遇水呈非凝胶状态的头孢呋辛酯胶囊及其制备方法
  • IP10一种遇水呈非凝胶状态的头孢菌素酯类药物颗粒、其制备方法和应用
  • IP11一种头孢呋辛酯片及其制备方法
  • IP15 一种长效脉冲制剂及其制备方法
  • IP16一种质子泵抑制剂胶囊及其制备方法
  • IP17一种治疗溃疡性结肠炎的灌肠剂及其制备方法
  • IP18一种高生物利用度的伊曲康唑胶囊剂2022104092492)
  • IP19一种替米沙坦微丸及其制备方法和药物制剂
  • IP20一种药物组合物及其制备方法
  • IP21一种抑菌组合物、抑菌制剂及其制备方法与应用
  • IP22一种替米沙坦氨氯地平单层片及其制备方法
  • IP23一种含利那洛肽的药物组合物、胶囊制剂及其制备方法
  • IP24一种头孢地尼药剂及其制备方法
  • IP25药物组合物、伊曲康唑微丸及制备方法与伊曲康唑胶囊
  • IP26伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊
  • IP27一种高稳定性盐酸西替利嗪片剂及其制备方法
  • IP28一种中药组合物和洗鼻剂及其制备方法和应用
  • IP29一种用于治疗或预防周围性面瘫型唾液分泌障碍的中药组合物及其制
  • IP30一种含瑞巴派特颗粒及其制备方法和应用
  • IP31果酱和难溶性药物混合物中难溶性药物的提取及检测方法
  • IP32一种聚卡波非钙干混悬剂及其制备方法与应用
  • IP33帕利哌酮缓释片及其制备方法
  • IP34一种含苏沃雷生的眼用制剂及其制备方法
  • IP35一种口腔牙齿清洁剂及其制备方法
  • IP36一种水凝胶美容液及其制备方法
  • IP37一种干混悬剂及其制备方法
  • 20240909 GMP符合性检查告知书
  • 20240129药品GMP符合性检查结果告知书807866931743273225
  • 江苏省药品监督管理局药品GMP符合性检查结果公告(2022年第18号)
  • 20180929GMP证书
  • 粉针剂GMP证书完整版20140306
  • 中化固型剂GMP证书20140303
  • 20100802固体制剂GMP
  • 20100715粉针剂GMP证书
  • 20050930粉针剂GMP证书
  • 20050817片剂GMP证书
  • 19980623GMP认证
  • 2023.12.24-2028.12.23 Cilostazol Tablets (Certificate of Foreign Pharmaceutical Manufacturer)
  • 20181120PMDA证书 医药品一般
  • 20181120PMDA证书医药品外用 一般
  • 2014.05外国制造业者认定(医药部外品一般)
  • 20131224医药品外国制造业者认定(医药品一般)
  • 20120822医药品外国制造业者认定(医药品一般)